Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial

Autor: Venhoff, Nils, Schmidt, Wolfgang A, Bergner, Raoul, Rech, Jürgen, Unger, Leonore, Tony, Hans-Peter, Finzel, Stephanie, Andreica, Ioana, Kofler, David M, Weiner, Stefan M, Lamprecht, Peter, Schulze-Koops, Hendrik, App, Christine, Pournara, Effie, Mendelson, Meryl H, Sieder, Christian, Maricos, Meron, Thiel, Jens ^*

Publikováno v: In The Lancet Rheumatology June 2023 5(6):e341-e350

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma

Autor: Euskirchen, Philipp, Radke, Josefine, Schmidt, Marc Sören, Heuling, Eva Schulze, Kadikowski, Eric, Maricos, Meron, Knab, Felix, Grittner, Ulrike, Zerbe, Norman, Czabanka, Marcus, Dieterich, Christoph, Miletic, Hrvoje, Mørk, Sverre, Koch, Arend, Endres, Matthias, Harms, Christoph

Externí odkaz: https://hdl.handle.net/1956/17540

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma.

Autor: Euskirchen P; Dept. of Neurology, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Dept. of Experimental Neurology, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany., Radke J; Berlin Institute of Health (BIH), Berlin, Germany.; Dept. of Neuropathology, Charité -Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Charité Berlin, Berlin, Berlin, Germany., Schmidt MS; Dept. of Experimental Neurology, Charité -Universitätsmedizin Berlin, Berlin, Germany., Schulze Heuling E; Dept. of Experimental Neurology, Charité -Universitätsmedizin Berlin, Berlin, Germany., Kadikowski E; Dept. of Experimental Neurology, Charité -Universitätsmedizin Berlin, Berlin, Germany., Maricos M; Dept. of Experimental Neurology, Charité -Universitätsmedizin Berlin, Berlin, Germany., Knab F; Dept. of Experimental Neurology, Charité -Universitätsmedizin Berlin, Berlin, Germany., Grittner U; Center for Stroke Research Berlin, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Dept. for Biostatistics and Clinical Epidemiology, Charité -Universitätsmedizin Berlin, Berlin, Germany., Zerbe N; Dept. of Pathology, Charité -Universitätsmedizin Berlin, Berlin, Germany., Czabanka M; Dept. of Neurosurgery, Charité -Universitätsmedizin Berlin, Berlin, Germany., Dieterich C; Computational RNA Biology and Ageing Group, Max-Planck-Institute for the Biology of Ageing, Cologne, Germany., Miletic H; Dept. of Biomedicine, University of Bergen, Bergen, Norway.; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Mørk S; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Koch A; Berlin Institute of Health (BIH), Berlin, Germany.; Dept. of Neuropathology, Charité -Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Charité Berlin, Berlin, Berlin, Germany., Endres M; Dept. of Neurology, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Dept. of Experimental Neurology, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Center for Stroke Research Berlin, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Standort Berlin, Berlin, Germany.; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Standort Berlin, Berlin, Germany., Harms C; Dept. of Experimental Neurology, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany.; Center for Stroke Research Berlin, Charité -Universitätsmedizin Berlin, Berlin, Germany.

Publikováno v: PloS one [PLoS One] 2017 Sep 25; Vol. 12 (9), pp. e0185376. Date of Electronic Publication: 2017 Sep 25 (Print Publication: 2017).